References
- Lachman HM, Papolos DF, Saito T, et al. Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders. Pharmacogenetics 1996; 6: 243–50
- Li T, Chen CK, Hu X, et al. Association analysis of the DRD4 and COMT genes in methamphetamine abuse. Am J Med Genet (Neuropsychiatr Genet) 2004; 129B: 120–4
- Hosák L, Csémy L, Preiss M, Čermáková E. Predikce úspěšnosti ústavní odvykací léčby u závislých na metamfetaminu. Czech Slov Psychiatry 2005; 101: 82–7
- Hosák L, Preiss M, Halíř M, Čermáková E, Csémy L. Temperament and character inventory (TCI) personality profile in metamphetamine abusers: a controlled study. Eur Psychiatry 2004; 19: 193–5
- Minarik M, Minarikova L, Bjorheim J, Ekstrom PO. Cycling gradient capillary electrophoresis (CGCE): A low cost tool for high-throughput analysis of genetic variations. Electrophoresis 2003; 24: 1716–22
- Feusner J, Ritchie T, Lawford B, et al. GABAA receptor β3 subunit gene and psychiatric morbidity in a post-traumatic stress disorder population. Psychiatry Res 2001; 104: 109–17
- Lee HS, Kim SH, Lee HJ, et al. Gender-specific molecular heterosis of dopamine D2 receptor gene (DRD2) for smoking in schizophrenia. Am J Med Genet (Neuropsychiatr Genet) 2002; 114: 593–7
- Bau CHD, Almeida S, Hutz M. The TaqI A1 allele of the dopamine D2 receptor gene and alcoholism in Brazil: Association and interaction with stress and harm avoidance on severity prediction. Am J Med Genet (Neuropsychiatr Genet) 2000; 96: 302–6
- Comings DE, MacMurray JP. Molecular heterosis: A review. Mol Genet Metab 2000; 71: 19–31